Inês Martins, PhD, managing science editor —

Inês holds a PhD in biomedical sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied cell and molecular biology and worked as a research fellow at multiple institutes. In addition to several college awards, Inês won the Pfizer Basic Research Award in 2012 for a research paper. She also has a graduate degree in data science.

Articles by Inês Martins

Kyprolis Combo Seen to Improve Life Quality in Relapsed Multiple Myeloma Patients

Adding the proteasome inhibitor Kyprolis (carfilzomib) to the standard two-drug regimen of Revlimid (lenalidomide) and dexamethasone significantly improves health-related quality of life in relapsed multiple myeloma patients, according to a secondary analysis of the ASPIRE clinical trial. These findings, published in the Journal of Clinical Oncology, further support the…

Multiple Myeloma Patients Treated at Higher-volume Facilities Have Better Outcomes, Study Finds

Patients treated for multiple myeloma at facilities that see a higher number of multiple myeloma patients annually had better outcomes compared to patients who were treated at lower-volume facilities, researchers at the Mayo Clinic found. The research study, “Association Between Treatment Facility Volume and Mortality of Patients With Multiple Myeloma,” was…